GPs in 30 practices (n = 63) purposively selected to reflect a range of practice characteristics and levels of antidepressant prescribing.
INTRODUCTION
Levels of antidepressant prescribing have dramatically increased in Western countries in the last two decades. [1] [2] [3] [4] [5] [6] [7] [8] The reasons for this increase are not clear, but in Scotland they are not due to an increase in the incidence or prevalence of depression, or recorded help-seeking behaviour by patients. 9 Most cases of depression in the UK are managed entirely in primary care and the vast majority of prescriptions for antidepressants are issued by GPs. 10 GPs have, therefore, played a central role in the rise of antidepressant prescribing.
Concern about the risk of inadequate recognition and treatment of depression in the late 1980s and 1990s (addressed, for example, by The Defeat Depression Campaign 11 ) is now matched by a concern that antidepressants may be prescribed inappropriately. 12 Doctors have been criticised for 'medicalising' social problems. 13 There is large variation in prescribing antidepressants between practices, and the current authors have previously demonstrated that almost half of this variation between practices can be explained by population, GP, and practice characteristics.
14 To understand better the increase and variation in antidepressant prescribing, the current researchers interviewed GPs about their management of depression, with a particular focus on antidepressant prescribing. This paper presents GPs' reflections on the reasons for the rise in antidepressant prescribing.
METHODS

Sample
All GP practices across Scotland were allocated to a sampling frame to facilitate purposive sampling. The frame consisted of a three-by-three matrix generated by two characteristics: (1) high, medium, and low levels of prescribing; and (2) high, medium, and low rates of increase in antidepressant prescribing. The aim was to recruit a purposive sample of 30 practices from across Scotland. The level of prescribing, using defined daily doses (DDDs), was calculated with data for financial year 2003/4, and the rate of increase in antidepressant prescribing was calculated comparing prescribing from 1995/6 with 2003/4. Prescribing data were accessed retrospectively from a national dataset of all prescriptions dispensed in Scotland and, as such, 2003/4 was the most recent data available at the time of the study. One researcher carried out the practice selection. This ensured a mix of practices with respect to sex and age of partners, number of partners, size of practice, training status, deprivation, and rurality (Tables 1 and 2 ). The interviewer was blind to which cell of the matrix practices occupied.
As prescribing data are available only by GP practice and not by individual GP, it was appropriate that practices, rather than individual GPs, were recruited. At least half of the GPs in a practice had to agree to be involved for inclusion of their practice. Each GP in the practice was initially contacted by letter and followed up by telephone call within 2 weeks. GPs were given the option of individual, group, or telephone interviews.
Qualitative interviews
All interviews were conducted by one researcher during 2005 and 2006. The interviews were semistructured. A topic guide ensured that specific areas were covered but was flexible enough to allow additional themes to emerge. The topic guide consisted of a series of key themes including 'possible explanations for the rise in antidepressant prescribing', 'depression management', and 'influences on prescribing'. Interviews lasted around 60 minutes and were taped and transcribed verbatim.
Analysis
Data analysis was inductive, continuous, and began from the start of data collection. While the analysis did not adhere strictly to a single analytic strategy, the method adopted in the Framework Approach 15 was drawn on, meaning that the original aims of the
How this fits in
With limited access to psychological therapies, GPs face difficult decisions regarding whom to refer. Little is known as to how they make these decisions. In the current qualitative study, GPs described themselves as considering a patient's wishes for and interest in referral, the patient's capacity to benefit from psychological therapy, and their own capacity to help the patient. They balanced likely effectiveness of psychological therapy for each patient with their own ability to help.
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RESULTS
Participants
Eighty-six practices were invited to take part in the study and 30 agreed. A total of 63 GPs (41 male and 22 female) were interviewed. As all practices had been entered into the sampling frame, selecting practices from all of the cells in the matrix ensured that a broad range of practices were involved (Tables  1 and 2 ). Telephone interviews were carried out with individual GPs in six practices and the remaining 24 practices opted for face-to-face interviews. Three practices preferred group interviews. These included two or three GPs and followed the traditional interview model, rather than a focus group.
Prescribing trends
Without exception, GPs recognised that there had been an increase in antidepressant prescribing since 1992, though few could predict the level of increase. Many GPs were surprised that prescribing levels had risen so steeply, particularly as they did not recognise a corresponding increase in the incidence or prevalence of depression. Most GPs believed that their own prescribing had increased over the same period, albeit to a lesser degree than the national average. 16 Many felt uneasy about the increased use of antidepressants, although it was not always clear whether this uneasiness related to recent criticism of prescribing practice, or whether they thought that the level of prescribing was inherently 'wrong'.
When explaining the rise in prescribing, change was a constant theme. GPs did not see themselves as drivers of change, but instead as responding to external pressures. The changes they described will be considered in relation to three issues: recognition of depression, patient circumstances, and treatment of depression.
Recognition of depression
The core message of The Defeat Depression Campaign, launched in 1992 by the Royal College of Psychiatrists and the Royal College of General Practitioners (RCGP), was that depression was inadequately detected and treated in general practice. 11 While few GPs interviewed mentioned this GPs reported that it is now more common for patients to self-diagnose depression and present to primary care simply for treatment. A number commented on the unique nature of depression, as a diagnosis patients 'demand'. GPs felt that this was tied to increased patient knowledge, particularly of antidepressant medication. A number were cynical about patient familiarity with 'depression' and many saw this as a negative consequence of raising its profile. Some talked about patients' misconceptions, believing that many see antidepressants as 'happypills' or 'lifestyle' drugs, offering a 'quick-fix'. This does not apply to all patients. GPs also recognised that some people would resist a diagnosis of depression and remain largely resistant to antidepressant medication.
Patients' expectations
GPs believe that many patients think that depression has a 'simple' solution that can be provided by their doctor. A causal relationship was described in relation to familiarity with the symptoms of depression, the increase in experience of depression in the community, and misconceptions about depression, leading to increased help-seeking. GPs talked of patients' expectations and felt that there are some people who assume that life will be continuously happy: 
'Priests of yesteryear': the social role of GPs
The majority of GPs described a social climate in which depressive symptoms flourished. Socioeconomic deprivation, family breakdown, the secularisation of society, increased debt, fear of crime, social isolation, and drug and alcohol misuse were all mentioned. Such social ills have caused community fragmentation, which has created a void that results in patients turning to GPs for help. Patients, GPs believe, are affording them an everexpanding role which was summed up by one GP who commented that they have become the 'priests of yesteryear'.
Medicalising misery
GPs thought that they were often the first or only professional to be consulted about the impact of personal and social problems on their patients' lives. This led GPs to question repeatedly whether they are treating depression or the effects of difficult or 'miserable' lives. The challenge was to differentiate between those patients who are genuinely depressed and those that are merely 'fed up', often with 'difficult' social circumstances. Some questioned the appropriateness of their response to these issues in practice: 
'I don't think that's just as simple as medicalising unhappiness, probably you know a lot of the antidepressant prescribing we do it would be great to prescribe them a holiday or a job.' (PR 20, GP B)
GPs acknowledged that prescribing is only one option that is available for the management of depression but felt that other therapies were scarce and 'patchy'. Even though more appropriate interventions were often unavailable, GPs still needed to treat their patients. This led to reliance on what was described as the 'coal face option' of antidepressants. Many GPs were clearly frustrated with this situation:
'We've been hounded for so long that we were missing depression now we're, in a way, perhaps we're over diagnosing or perhaps we're treating more mild depression that in the past people would just have got on with. I mean, it then becomes quite subtle whether or not somebody's degree of unhappiness is tipping them into a mild depression or is it just life, and that's a bit of a fine line.' (PR 24, GP C)
Selective serotonin reuptake inhibitors: the 'safer', 'coal face option'
By far the single biggest change reported by GPs has been the advent of selective serotonin reuptake inhibitors (SSRIs). Established antidepressants, or 'old style' tricyclics, as they were often called, are now rarely used as first line treatment for depression. Many talked of the problems associated with tricyclics, particularly the unpleasant side effects and problems with overdose. One interviewee stated 'you had to have a pretty good reason to be on one'. Similar language was not used to describe SSRIs. There is no doubt that the majority saw SSRIs as safer, cleaner, cheaper drugs that can be tolerated by more patients: Few GPs made direct links between the availability of SSRI medication and the rise in prescribing rates. Nevertheless, the way in which they described the drugs, their confidence in prescribing them, and the almost total acceptance of their safety does suggest a causal relationship. The following quote hints that confidence in prescribing an SSRI could lead to over prescribing but also a practical solution:
'I don't think everybody who gets treated [with an SSRI] even in this practice or even by me necessarily would fulfil strict criteria, but it is one of these things that's relatively easy and pretty safe to do and is a coal face option.' (PR 8, GP A)
Some talked about living through 'fashions' in prescribing practice. They had noted recent negative publicity about SSRIs and felt that public opinion could now be turning against these drugs. Nevertheless, concerns about suicide and dependency were largely restricted to one specific SSRI (paroxetine). 17 Other drugs continued to enjoy almost universal approval, and their safety was not questioned; although one GP did question the wisdom of life-time SSRI use. The perceived tolerability of SSRIs relative to tricyclics may have led to the view that they are not only safer but also 'milder' in their actions and side effects, thus allowing for the pharmacological treatment of 'milder' disease.
Contemporary thinking no longer makes a distinction between traditional concepts of 'endogenous' (biological) depression and 'reactive' (social) depression. Current prescribing guidelines 18 emphasise the need to treat symptoms of depression, whether or not social or personal factors may have influenced an episode of low mood. However, some GPs discussed depression in terms of biological/endogenous or social/reactive depression. These doctors tended to be older, whereas younger GPs described depression in terms of severity, and focused on the treatment of symptoms rather than causes: 
Influence of guidelines
Only one GP interviewed attributed the rise in antidepressant prescribing to adherence to best practice guidelines from the National Institute for Health and Clinical Excellence, namely, treating patients for a longer period of time; and another mentioned this among a series of possible explanations. GPs, however, typically reported prescribing for at least 6 months after the patient felt better, in line with guidelines.
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Influence of pharmaceutical industry
The impact of widespread tolerability and perceived safety of SSRIs on prescribing was only hinted at by a few. Others, however, emphasised the influence of the pharmaceutical industry at a macro level: GPs were asked directly about the potential influence of pharmaceutical companies. The vast majority reported that they 'did not see drug reps', although a few mentioned the power of advertising in medical journals. Nevertheless, when drug choice was discussed, some who dismissed the influence of 'reps' went on to talk about the prescription of nonformulary compliant drugs, which suggests that the advertising campaigns of the pharmaceutical industry may be more pervasive than GPs acknowledge.
Universality of themes
Practices were chosen to reflect the whole range of types of practices and behaviour in prescribing antidepressants. Although the interviewer was blind to the prescribing level and pattern in practices during the interviews, this information was available e304 e305 at analysis. This study compared transcripts from GPs in high prescribing practices and those in low prescribing practices but could find no evidence of a systematic difference in the comments made.
DISCUSSION
Summary of main findings
GPs in this study were aware of the increase in prescribing antidepressants and many were uneasy about it, although the drivers for the increase were considered to be largely external. These drivers included campaigns in the 1990s aimed at encouraging GPs to increase their recognition and active management of depression and, by reducing stigma, to encourage patients to present with symptoms of depression. Other explanations included a growing focus on 'good' mental health, encouraged by successive government campaigns to reduce stigma around mental ill health; the perceived trend towards the medicalisation of difficult lives coupled with a lack of availability of alternative management options; increasing social malaise; and the availability of SSRIs. It is not surprising that prescribing has increased, particularly as GPs have become better at diagnosing depression and because the drug treatments available are considered to be 'better'.
Strengths and limitations of the study
This study has been able to capture GPs' attitudes towards antidepressant prescribing. The focus was on general and collective prescribing behaviour rather than focusing on their actual prescribing behaviour with individual patients. This enabled some of the more controversial aspects of prescribing to be discussed openly.
The sampling frame ensured that experiences of GPs with all levels of prescribing were accessed. However, participation in the study was voluntary, and it is likely that GPs who were interested in mental health, comfortable with their prescribing practice, and prepared to reflect on this would be more likely to take part. Recruiting by practice ensured that a breadth of views were gained, but it also meant that some GPs who wanted to participate, particularly those in larger practices, could not do so if their colleagues did not wish to be involved. Previous research has demonstrated that this is not due to an increase the presentation or recording of depression. 9 In fact, consultations for depression have fallen significantly since 2003/4. 21 This apparent contradiction may be partly explained by methods used to measure prescribing. GPs' sub-therapeutic prescribing (as was common with tricyclic drugs) is less possible with SSRIs, resulting in increased levels of DDDs of antidepressants prescribed without an increase in the number of patients being treated. 22 In addition, GPs acknowledged that they are sometimes managing the impact of patients' difficult lives. Their difficulty in determining the boundaries of 'misery' and clinical depression might account for the lack of recording of such conditions as 'depression'.
Comparison with existing literature
The GPs interviewed believe that a range of outside pressures have influenced their prescribing, including the pastoral role in addition to the clinical role. It has been argued that GPs are now the 'default sources of comfort for issues such as bereavement, social isolation, and loneliness'. 23 Other researchers have suggested a range of contributing factors; for example, the prescribing of antidepressants for other problems such as anxiety 24 or prescribing at higher doses for longer duration as recommended in guidelines. 19 In this study, guidelines were not mentioned by GPs as having a major influence, although most described prescribing behaviour, which indicated adherence to guidelines on duration of treatment.
GPs in this study felt that there had been an increase in the presentation of depression due to the success of campaigns to increase recognition and reduce stigma relating to mental health problems. For example, 'see me', the government-funded Scottish anti-stigma initiative, has conducted high profile media campaigns since 2002, and in 2003 the initiative reached an estimated 89% of the population through television advertising. 25 Although early evaluations of The Defeat Depression Campaign demonstrated conflicting results, [26] [27] [28] the Editor of the British Journal of General Practice commented in 1999 that 'what matters in the long term is how the messages of the campaign are taken up by individual practice teams and how quickly new research ... is taken up in day-to-day practice'. 29 We believe that there is evidence from the current study that The Defeat Depression Campaign (strengthened by subsequent guidelines) has influenced practice. This view reflects the 'accumulation model of change' where the repetition of messages, particularly in respected journals, results in long-term change. 30 This study did not find clear differences in views between GPs working in urban and rural settings, or between high and low prescribing doctors. Other studies have not shared this finding. 31, 32 This may be because GPs attribute a large part of the increase in prescribing to the need to support patients in difficult life circumstances. While such difficulties may be more prevalent in deprived practices, they are present across a range of practice settings. GPs collectively described the newer SSRIs as safer drugs that provided a 'coal face option' in the absence of alternatives. They expressed their discomfort at prescribing for what they felt were a complex mix of material disadvantage, early adversity, relationship issues, and maladaptive coping strategies. A perceived 'consumerism' in society was felt to lead to patients seeking medical/pharmaceutical help for problems with more complex personal and social origins. This is concordant with others' findings on GPs' emotional reactions to their prescribing and the discomfort they often feel 33 when their only recourse is to prescribe medication while recognising more complex circumstances. 34 The emotional conflict for GPs is exacerbated by their desire to help people in distress and the inadequate range of options open to them.
While managing the reality of the individual patient consultation, GPs in this study were keenly aware of the wider, societal concern surrounding the increase in prescription of antidepressants. Charges of ambivalence in prescribing decisions were rejected and this is confirmed by recent research that shows that GPs do not prescribe antidepressants without a clinical basis.
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Implications for future research and clinical practice
The Scottish government is concerned about the rate of increase in prescribing of antidepressants and has set a target to 'reduce the annual rate of increase of defined daily dose per capita of antidepressants to zero by 2009/10 and put in place the required support framework to achieve 10% reduction in future years.' 36 To achieve this, GPs require alternative management options for those patients whose 'mild' depression is not best managed with antidepressants. Use of severity when labelling depression can be unhelpful in primary care. The implication is that 'mild' depression poses less of a challenge to GPs, yet 'mild' often represents a complex picture of psychosocial difficulty and distress that fails to fit easily into 'symptom counting' definitions and is arguably harder to manage.
The process of change, in the context of GPs' antidepressant prescribing, will not happen overnight and will only occur with consistently reinforced evidence for change. The evidence base for 'appropriate' prescribing does not yet exist, but it is perhaps more important to pursue 'appropriate' management, which in many cases will include both antidepressants and 'talking therapies' for some, and self-help or alternative strategies for others. This may help to alleviate some of the concerns GPs expressed about their role, particularly in managing mild depression.
Health policy in Scotland is developing to support greater access to psychological therapies and improve access to better quality assessment for depression, as reflected in the current Integrated Care Pathway for Depression Guidelines. 37 This policy direction is consistent with the problems identified by GPs in this study. Further work is required to investigate the potential for nonpharmacological approaches to support recovery from depression adequately. Given the scale of the problem, work will also be needed to review 'service delivery systems' with the capacity to cope with demand for help with depression in primary care.
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